These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39507967)

  • 1. [Clinicopathological Features and Outcomes of Perioperative Treatment for Small Cell Carcinoma of the Bladder].
    Deng J; Zhang M; Yang M; Zhang P; Shen Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Sep; 55(5):1078-1084. PubMed ID: 39507967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of early stage small cell bladder cancer is not always dismal.
    Lim JH; Sundar S
    ESMO Open; 2019; 4(6):e000559. PubMed ID: 31798978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews.
    Chen Z; Liu Q; Chen R; Liu Z; Li M; Ling Q; Wu L; Yang J; Liu X; Wang T; Hu Z; Guo X; Wang S; Yang W; Liu J
    World J Surg Oncol; 2017 Jan; 15(1):33. PubMed ID: 28125986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.
    Cattrini C; Cerbone L; Rubagotti A; Zinoli L; Latocca MM; Messina C; Zanardi E; Boccardo F
    Clin Genitourin Cancer; 2019 Aug; 17(4):e724-e732. PubMed ID: 31160193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome.
    van de Kamp M; Meijer R; Pos F; Kerst M; van Werkhoven E; van Rhijn B; Horenblas S; Bex A
    Urol Oncol; 2018 Jun; 36(6):307.e1-307.e8. PubMed ID: 29580697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients.
    Pasquier D; Barney B; Sundar S; Poortmans P; Villa S; Nasrallah H; Boujelbene N; Ghadjar P; Lassen-Ramshad Y; Senkus E; Oar A; Roelandts M; Amichetti M; Vees H; Zilli T; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):904-10. PubMed ID: 26104942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and survival of non-metastatic small cell carcinoma of the bladder from multiple centers in China.
    Lu J; Zhou J; Liu Y; Li Y; Tang Y; Li N; Wang S; Song Y; Zhang W; Xiang X; Jin J
    Sci Rep; 2024 Oct; 14(1):24652. PubMed ID: 39428391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Outcomes for Small Cell Carcinoma of the Bladder: Results From a UK Patient Retrospective Cohort Study.
    Chau C; Rimmer Frcr Y; Choudhury PhD A; Leaning Frcr D; Law A; Enting D; Lim Md JH; Hafeez PhD S; Khoo PhD V; Huddart PhD R; Mitchell Frcr D; Henderson Frcr DR; McGrane Frcr J; Beresford Frcr M; Vasudev PhD N; Beesley Frcr S; Hilman S; Manetta Frcr C; Sriram Frcs R; Sharma Md A; Eswar Frcr C; Treece Frcr S; Vilarino-Varela Frcr M; Varughese Frcr M; Glen PhD H; Pintus Md E; Crabb PhD S
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1143-1150. PubMed ID: 33561506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
    Li Q; Assel M; Benfante NE; Pietzak EJ; Herr HW; Donat M; Cha EK; Donahue TF; Bochner BH; Dalbagni G
    Eur Urol Focus; 2019 Jan; 5(1):104-108. PubMed ID: 28753857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
    Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
    Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy.
    Teo MY; Guercio BJ; Arora A; Hao X; Regazzi AM; Donahue T; Herr HW; Goh AC; Cha EK; Pietzak E; Donat SM; Dalbagni G; Bochner BH; Olgac S; Sarungbam J; Sirintrapun SJ; Chen YB; Gopalan A; Fine SW; Tickoo SK; Reuter VE; Weigelt B; Schultheis AM; Funt SA; Bajorin DF; Solit DB; Iyer G; Ostrovnaya I; Rosenberg JE; Al-Ahmadie H
    Clin Genitourin Cancer; 2022 Oct; 20(5):431-441. PubMed ID: 35676169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis.
    Bruins HM; Aben KK; Arends TJ; van der Heijden AG; Witjes AJ
    Urol Oncol; 2016 Apr; 34(4):166.e1-6. PubMed ID: 26705102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
    Koay EJ; Teh BS; Paulino AC; Butler EB
    Cancer; 2011 Dec; 117(23):5325-33. PubMed ID: 21567387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    Evers PD; Logan JE; Sills V; Chin AI
    World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder.
    Meijer RP; Meinhardt W; van der Poel HG; van Rhijn BW; Kerst JM; Pos FJ; Horenblas S; Bex A
    Int J Urol; 2013 Aug; 20(8):778-84. PubMed ID: 23231456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
    Naito A; Taguchi S; Nakagawa T; Matsumoto A; Nagase Y; Tabata M; Miyakawa J; Suzuki M; Nishimatsu H; Enomoto Y; Takahashi S; Okaneya T; Yamada D; Tachikawa T; Minowada S; Fujimura T; Fukuhara H; Kume H; Homma Y
    World J Urol; 2017 Jan; 35(1):97-103. PubMed ID: 27180266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
    Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
    Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
    Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
    JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder.
    Stensland KD; Zaid H; Broadwin M; Sorcini A; Canes D; Galsky M; Moinzadeh A
    Eur Urol Oncol; 2020 Aug; 3(4):509-514. PubMed ID: 31411987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.